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U
 
ncontrolled lymphoproliferation is a characteristic fea-
ture of lymphomas and leukemias. Nonmalignant lym-
phoproliferative diseases are also observed in humans as well
 
as in 
 
lpr
 
 (lymphoproliferation) and 
 
gld
 
 (generalized lymphad-
enopathy) mice. The discoveries that spontaneous mutations
of Fas (APO-1/CD95) or its ligand (FasL) were associated
 
with the 
 
lpr
 
 and 
 
gld
 
 phenotypes led to a satisfying explana-
tion as to how deficiency of a pivotal lymphocyte apoptotic
 
pathway (Fas–FasL) caused accumulation of activated lym-
phocytes in the peripheral immune system (1). A second
important consequence of the failure to delete activated cells
of the immune system is systemic autoimmunity—which
can be explained by the persistence of potentially self-reac-
tive T cells and, most likely, antigen-presenting cells in the
peripheral immune system (2).
The remarkable strides made in defining the cellular
biochemistry of apoptosis over the last 5 years have led to
several predictions of protein function that, most definitively,
could be tested by gene targeting in mice. Early predictions
were that deletion of components of the Fas signal trans-
 
duction pathway would lead to a phenotype similar to
 
lpr
 
. Deletions of Fas-associated death domain (FADD) or
caspase-8 were lethal in the embryo due to impaired cardiac
development, and were therefore uninformative regarding
mature T cell function (3, 4). However, FADD-deficient T
 
cells in recombination activating gene (RAG)-1
 
2
 
/
 
2
 
 mice
or transgenic mice expressing a dominant negative FADD
protein were completely resistant to Fas-mediated apoptosis,
 
as expected, but demonstrated reduced T cell proliferation
rather than lymphoproliferation and autoimmunity (5, 6).
The results of the studies by Alam et al. (7) and Kennedy
et al. (8) in this issue provide a potential explanation for the
contrasting effects of Fas versus FADD deficiency. Both
studies report that, in addition to the well-defined role of
upstream caspases in initiating the proteolytic cascade re-
quired for the inactivation and packaging of cellular con-
stituents in apoptosis, caspases are necessary for prolifera-
tion of primary human T cells in vitro. This conclusion was
based on two major observations: (a) T cell proliferation
was inhibited by cell-permeable caspase inhibitors, and (b)
caspases were cleaved within hours after CD3 engagement.
Although these data are compelling, some caveats should
be noted. Most commercially available irreversible caspase
inhibitors are not absolutely specific for any individual
caspase, so that precise intracellular targets cannot be certain
(9). Could these inhibitors be exerting a “toxic” effect on
primary T cells, thus accounting for their lack of prolifera-
tion? Alam et al. (7) have made considerable efforts to ex-
clude this possibility: caspase-3 cleavage was observed in
activated T cells that were sorted on the basis of failure to
bind annexin V, a marker of early cell death. These authors
also used cell-permeable fluorescent caspase substrates to
avoid artefactual activation of caspases arising from me-
chanical disruption of the cell, which complicated the in-
terpretation of previous studies (10, 11).
Key to understanding the significance of the observations
reported by Alam et al. (7) and Kennedy et al. (8) is the
 
identification of the earliest upstream “initiator” caspase, most
likely caspase-8, that is activated after CD3 ligation as well
as the substrates of this caspase. In its pro-form, caspase-8
 
exists as an inactive 56-kD precursor that is recruited to a
death receptor from the cytosol to form the DISC (death-
inducing signaling complex) through the adapter protein
FADD. Caspase-8 is sequentially cleaved into 41/43- (large
subunit) and 12-kD (small subunit) intermediates followed
by 26- and 18- (large subunit) and 10- and 2-kD (small
subunit) products (12). In neither study reported in this is-
sue were the catalytically active fragments (18 and 10 kD)
clearly demonstrated within the first day after T cell activa-
 
tion, although the presence of the 
 
z
 
26-kD peptide implies
cleavage of the large subunit. In contrast to these studies,
Scaffidi et al. (13) observed that there was very little recruit-
ment of FADD or caspase-8 to form a DISC within the first
day after mitogen activation of T cells, and that catalytically
 
active fragments of caspase-8 were not detected. These
contrasting findings raise the question as to whether other
caspases and/or Fas binding proteins could be responsible
for promoting T cell proliferation.
Peripheral blood–derived T cells are a heterogeneous pop-
ulation that includes different functional subsets as well as
cells with varying life histories (naive, recently activated, and
memory cells). Could anti-CD3 provide a restimulation
(death) signal to a subpopulation of previously activated T
cells? Failure to detect caspase-3 activation in the study by
Kennedy et al. (8) would argue against this, as does a subset
analysis by Alam et al. (7). However, the two studies differ
significantly with regard to the extent of caspase activation
and its consequences. Whereas Kennedy et al. (8) did not
observe caspase 3 activation within 24 h after activation,
Alam et al. (7) detected cleavage of caspase-3, -6, and -7 as
well as selective proteolysis of the substrates poly(ADP-
ribose) polymerase (PARP) and lamin B in cells analyzed 
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16 h to 4 d after activation. Cleavage of the DNA repair
enzyme, PARP, and a structural component of the nuclear
membrane, lamin B, are striking findings and raise obvious
questions about cell viability.
The similarities between several of the morphologic fea-
tures of mitosis and apoptosis, such as dissolution of the nu-
clear membrane and chromatin condensation, suggested
that apoptosis can be likened to a “mitotic catastrophe” un-
der certain conditions (14). Therefore, it would not be sur-
prising to find similarities between some of the biochemical
pathways involved in these two opposing cell fates. During
cell division, the nuclear membrane to which lamins are
attached becomes vesiculated and dispersed within the cy-
tosol. Whereas cleavage of lamins has not previously been
reported in this context, it is well known that lamins are
phosphorylated, a posttranslational modification that is as-
sociated with depolymerization of the lamina into soluble
oligomeric units (15, 16). Similarly, cleavage (and inactiva-
tion) of PARP during T cell proliferation would not be ex-
pected to have any immediate deleterious consequences, as
PARP-deficient mice have an apparently normal immune
system (17).
Caspases do not function solely to inactivate proteins.
The first caspase identified, IL-1
 
b
 
–converting enzyme (ICE/
caspase-1), cleaves IL-1
 
b
 
 and IL-18 into their active proin-
flammatory cytokines (18). It is likely that caspase-4, -5, and
-11 play similar roles (19). In the context of apoptosis, many
cleavage events also result in enzyme activation. Apart from
their own autocatalytic conversion into active proteases,
caspases cleave inhibitory proteins such as inhibitor of
caspase-activated DNase (ICAD)/DNA fragmentation fac-
tor of 45 kD (DFF45) to release an active DNase, and they
cleave proteins within the bcl-2 family to promote proapop-
totic effects and regulatory proteins such as gelsolin to ren-
der this protein constitutively active for actin degradation.
Therefore, these activities define two functional categories,
one related to promotion of inflammation and the other to
the promotion of apoptosis. In addition, a significant num-
ber of caspase substrates have been identified for which the
functional significance remains unclear (9, 19). These sub-
strates include kinases (c-Jun NH
 
2
 
-terminal kinases [JNKs],
PITSLRE kinase, protein kinase C-
 
d
 
, p21-activated kinase 2
[PAK2K]), many of which have pleiotropic functions. For
example, JNK activation may cause T cell proliferation or
apoptosis, depending on the duration of JNK expression
(20). Taken together with the reports in this issue (7, 8), a
third category of caspase function, cell proliferation, can now
be proposed.
Several questions remain to be addressed. If caspase-8
cleavage is required for T cell proliferation, how do Fas-
deficient mice or humans (21, 22) develop massive lymphad-
enopathy and autoimmunity? One possibility is that other
death receptors such as TNF-R or DR3 that use the same
signal transduction pathways as Fas activate upstream caspases
so as to costimulate T cells in a similar fashion to Fas. Other
questions will need to be addressed, such as how does “high
dose” anti-CD3 lead to caspase-3 activation? Is this achieved
through increased transcription of autocrine FasL and/or
other “death” ligands, as suggested by Kennedy et al. (8)?
Why don’t transgenic mice that overexpress crm A (a cow-
pox-encoded protein that potently inhibits caspase-1 and
-8) have a defect in T cell proliferation (6)? Answers to these
questions will be illuminating.
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